Nelson J C, Weiss R M
J Clin Endocrinol Metab. 1985 Aug;61(2):239-46. doi: 10.1210/jcem-61-2-239.
Progressive dilution of normal sera causes little change in free T4 concentrations. Similar dilution of sera containing drug inhibitors of T4 binding to serum proteins causes a progressive fall in free T4. The low T4 syndrome of nonthyroidal illness is thought to be associated with a circulating inhibitor(s) of T4 binding. It would be expected, therefore, that dilution of sera from the low T4 syndrome might also result in a fall in free T4 concentrations. We compared the effect of progressive serum dilution on free T4 concentrations in low T4 syndrome sera to those in normal, hyperthyroid, pregnancy, TBG-deficient and salicylate-containing sera. A tracer dialysis method proved inappropriate for studying dilution effects. Using a new dialysate RIA method to measure free T4, we found a progressive fall in free T4 concentrations in sera from patients with the low T4 syndrome similar to that in serum containing salicylate, but not to that in normal sera. The magnitude of the fall varied widely among individual patients. Free T4 methods which use a diluted serum sample will underestimate free T4 concentrations in the low T4 syndrome.
正常血清的逐步稀释对游离甲状腺素(T4)浓度影响很小。含有抑制T4与血清蛋白结合药物的血清进行类似稀释会导致游离T4逐渐下降。非甲状腺疾病的低T4综合征被认为与循环中的T4结合抑制剂有关。因此,可以预期,低T4综合征患者血清的稀释也可能导致游离T4浓度下降。我们比较了低T4综合征血清、正常血清、甲状腺功能亢进血清、妊娠血清、甲状腺素结合球蛋白(TBG)缺乏血清和含阿司匹林血清中血清逐步稀释对游离T4浓度的影响。结果表明,示踪剂透析法不适用于研究稀释效应。采用一种新的透析液放射免疫分析法(RIA)测定游离T4,我们发现低T4综合征患者血清中游离T4浓度逐渐下降,这与含阿司匹林血清中的情况相似,但与正常血清不同。下降幅度在个体患者之间差异很大。使用稀释血清样本的游离T4检测方法会低估低T4综合征患者的游离T4浓度。